Search Results - "Lawhorn, S.L."

Use of Rapamycin One-Year Post Heart Transplantation Stabilizes Transplant Allograft Vasculopathy - The Mid America Experience by Kao, A, Eaton, M, Knutson, C, Linard, J, House, J, Austin, B.A, Everley, M.P, Khumri, T.M, Lawhorn, S.L, Magalski, A, Borkon, A.M, Safley, D

Get full text

178: Frequency of Gene Expression Profiling Use in Lieu of Endomyocardial Biopsy Post Heart Transplant Increases with Familiarity: The Mid America Experience by Kao, A, St Clair, K, Lawhorn, S.L, Magalski, A, Stevens, T.L, Borkon, A.M

Get full text

174: The Use of Gene Expression Profiling Post Heart Transplant in the Real World: The Mid America Experience by Kao, A, St Clair, K, Lawhorn, S.L, Magalski, A, Stevens, T.L, Borkon, A.M

Get full text

467: Low Immune Cell Function Assay Value Predicts Increased Risk for Cytomegaloviral, But Not Other Opportunistic Infections in Heart Transplant Patients: A Mid America Experience by Khumri, T.M, St Clair, K, Lawhorn, S.L, Magalski, A, Stevens, T.L, Borkon, A.M, Kao, A

Get full text

566 Serial Intravascular Ultrasound and Plaque Composition Analysis in Heart Transplant Recipients: A Single Center Experience by Rao, S.C, Khumri, T.M, House, J.A, Seifert, L, Murphy, J, Kao, A, Magalski, A, Stevens, T.L, Everley, M.P, St. Clair, K, Borkon, M, Lawhorn, S.L, Marso, S.P

Get full text

(108) - Variability of Both Raw and Transformed Gene Expression Profile Scores Predict Adverse Events Post Heart Transplant: The Mid America Experience by Beauchamp, S.R., Carl, K.R., Kennedy, K.F., Austin, B.A., Everley, M.P., Khumri, T.M., Lawhorn, S.L., Magalski, A., Sperry, B.W., Vodnala, D., Borkon, A.M., Dryton, G., Kao, A.

Get full text

(841) - Low Variability in Gene Expression Profile Scores Are Associated With Decreased Risk of Adverse Events Post Heart Transplantation: The Mid America Experience by Beauchamp, S.R., Carl, K.R., Kennedy, K.F., Austin, B.A., Everley, M.P., Khumri, T.M., Lawhorn, S.L., Magalski, A., Sperry, B.W., Vodnala, D., Borkon, A.M., Dryton, G., Kao, A.

Get full text

The Combined Use of Gene Expression Profile and Donor-Derived Cell-Free DNA Testing in the Management of Heart Transplant Patients: The Mid America Experience by Kao, A., Linard, J., Austin, B.A., Everley, M.P., Fendler, T.J., Khumri, T.M., Lawhorn, S.L., Magalski, A., Nassif, M.E., Sperry, B.W., Vodnala, D., Borkon, A.M.

“…Gene expression profile (GEP) testing has a high negative predictive value for <2R acute cellular rejection (ACR). Donor-derived cell-free DNA (dd-cfDNA)…”
Get full text

(1066) - Variability of Gene Expression Profile Scores Does Not Predict Coronary Allograft Vasculopathy as Detected by Intravascular Ultrasound One Year Post Heart Transplant: The Mid America Experience by Beauchamp, S.R., Kennedy, K.F., Brandt, H., Safley, D.M., Austin, B.A., Everley, M.P., Khumri, T.M., Lawhorn, S.L., Magalski, A., Sperry, B.W., Vodnala, D., Borkon, A.M., Carl, K.R., Dryton, G., Kao, A.

Get full text

A technique for the determination of left ventricular mass by signal-averaged electrocardiography by Botteron, G.W., Vacek, J.L., Wilson, D.B., Lawhorn, S.L.

“…Signal-averaged electrocardiography (SAECG) as a diagnostic tool is discussed. It is an accurate, noninvasive, and relatively inexpensive test that can…”
Get full text